{"id":29504,"date":"2025-10-20T20:02:00","date_gmt":"2025-10-21T00:02:00","guid":{"rendered":"https:\/\/www.americanonewspaper.com\/es\/?p=29504"},"modified":"2025-10-20T22:00:41","modified_gmt":"2025-10-21T02:00:41","slug":"nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina","status":"publish","type":"post","link":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/","title":{"rendered":"Nueva profilaxis que promete frenar el VIH, pero no llega a Am\u00e9rica Latina"},"content":{"rendered":"\n

Ciudad de M\u00e9xico, 20 oct (EFE).<\/p>\n\n\n\n

El lenacapavir podr\u00eda prevenir hasta 84.000 infecciones de VIH en Am\u00e9rica Latina para 2030, seg\u00fan estimaciones del Instituto Nacional de Salud P\u00fablica (INSP) de M\u00e9xico, pero su acceso sigue bloqueado por licencias privadas, precios inaccesibles y vac\u00edos regulatorios.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

El dato fue presentado este lunes durante el seminario \u201cActualizaciones en PrEP y acceso a lenacapavir en Latinoam\u00e9rica\u201d, organizado por el Instituto AHF de Salud P\u00fablica Global, que reuni\u00f3 a especialistas de distintos pa\u00edses para analizar las barreras regionales en el acceso a nuevas terapias de prevenci\u00f3n del VIH.<\/p>\n\n\n\n

Desarrollado por la farmac\u00e9utica Gilead, este es el primer antirretroviral inyectable de acci\u00f3n prolongada aprobado para la profilaxis preexposici\u00f3n (PrEP) que, a diferencia de la profilaxis oral diaria, se aplica mediante una inyecci\u00f3n subcut\u00e1nea cada seis meses y act\u00faa en tres fases del ciclo del virus.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Los ensayos PURPOSE 1 y 2, realizados en Sud\u00e1frica, Estados Unidos, Brasil, Argentina y M\u00e9xico, reportaron una eficacia del 96 % y una adherencia del 91 %, con apenas dos infecciones detectadas entre miles de participantes. \u201cLos problemas de adherencia podr\u00edan encontrar aqu\u00ed una soluci\u00f3n viable, especialmente entre j\u00f3venes y poblaciones clave\u201d, explic\u00f3 el doctor Ariel Terr\u00f3n, del Instituto AHF.<\/p>\n\n\n\n

Impacto potencial y desigualdad de acceso<\/strong><\/h2>\n\n\n\n

El an\u00e1lisis del INSP, dirigido por Tonatiuh Barrientos, model\u00f3 el impacto del medicamento en Argentina, Colombia, M\u00e9xico, Per\u00fa y Venezuela. En su escenario optimista, la reducci\u00f3n alcanzar\u00eda el 68 %, equivalente a 84.000 infecciones prevenidas entre 2026 y 2030.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

El estudio se apoya en datos de Onusida, que estima unas 110.000 nuevas infecciones por VIH en Am\u00e9rica Latina cada a\u00f1o, de las cuales el 40 % se registran en M\u00e9xico y Brasil.<\/p>\n\n\n\n

En contraste con su potencial, el acceso sigue restringido. En Estados Unidos, el lenacapavir cuesta 28.218 d\u00f3lares por persona al a\u00f1o, mientras que tratar a una persona con VIH cuesta 1.836 d\u00f3lares en M\u00e9xico.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

\u201cCon ese costo, ning\u00fan pa\u00eds latinoamericano puede implementarlo\u201d, advirti\u00f3 Jorge Saavedra, director del Instituto AHF. Record\u00f3 que solo Nicaragua, Honduras, Rep\u00fablica Dominicana, Bolivia y Venezuela, equivalentes al 10 % de la poblaci\u00f3n latinoamericana, fueron incluidos en el acuerdo global de Gilead, dejando fuera a los pa\u00edses con mayor carga epidemiol\u00f3gica.<\/p>\n\n\n\n

La activista colombiana Luz Marina Umbacia, de Public Citizen, denunci\u00f3 que las licencias voluntarias de la farmac\u00e9utica impiden que los gen\u00e9ricos lleguen a la regi\u00f3n. \u201cEl acceso a lenacapavir no puede ser un privilegio. Es una cuesti\u00f3n de justicia sanitaria\u201d, afirm\u00f3.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

A\u00f1adi\u00f3 que, adem\u00e1s, Gilead ha solicitado nuevas patentes en pa\u00edses como M\u00e9xico, lo que prolonga su monopolio y retrasa la entrada de versiones gen\u00e9ricas, aun cuando el medicamento ya est\u00e1 registrado en otras regiones. M\u00e1s de 100 organizaciones impulsan una campa\u00f1a regional para exigir transparencia, licencias equitativas y mecanismos de cooperaci\u00f3n que permitan su producci\u00f3n local.<\/p>\n\n\n\n

Desde el \u00e1mbito institucional, la doctora Georgina Morales, del Instituto Mexicano del Seguro Social (IMSS), record\u00f3 que M\u00e9xico ya cuenta con autorizaci\u00f3n de la Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) para pruebas piloto y con personal capacitado.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

\u201cTenemos la experiencia y la disposici\u00f3n, pero no el acceso. Estas estrategias deben complementar la PrEP oral, no reemplazarla\u201d, dijo.<\/p>\n\n\n\n

El seminario concluy\u00f3 que la \u00fanica v\u00eda para superar las barreras es negociar en bloque, dado que Am\u00e9rica Latina carece de mecanismos conjuntos de compra y fijaci\u00f3n de precios. \u201cLatinoam\u00e9rica tiene el conocimiento y la infraestructura, pero sigue fragmentada. Si negociamos juntos, podremos garantizar acceso y salvar miles de vidas\u201d, afirm\u00f3 Saavedra.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Ciudad de M\u00e9xico, 20 oct (EFE). El lenacapavir podr\u00eda prevenir hasta 84.000 infecciones de VIH en Am\u00e9rica Latina para 2030, seg\u00fan estimaciones del Instituto Nacional de Salud P\u00fablica (INSP) de M\u00e9xico, pero su acceso sigue bloqueado por licencias privadas, precios inaccesibles y vac\u00edos regulatorios. El dato fue presentado este lunes durante el seminario \u201cActualizaciones en […]<\/p>\n","protected":false},"author":14,"featured_media":29505,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"_acf_changed":false,"tdm_status":"","tdm_grid_status":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false},"categories":[1206,592,880],"tags":[],"class_list":{"0":"post-29504","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-america-latina","8":"category-salud","9":"category-vih"},"acf":[],"yoast_head":"\nNueva profilaxis que promete frenar el VIH, pero no llega a Am\u00e9rica Latina - Americano Newspaper<\/title>\n<meta name=\"description\" content=\"El lenacapavir podr\u00eda prevenir hasta 84.000 infecciones de VIH en Am\u00e9rica Latina para 2030, seg\u00fan estimaciones del Instituto Nacional de Salud P\u00fablica (INSP) de M\u00e9xico, pero su acceso sigue bloqueado por licencias privadas, precios inaccesibles y vac\u00edos regulatorios.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nueva profilaxis que promete frenar el VIH, pero no llega a Am\u00e9rica Latina\" \/>\n<meta property=\"og:description\" content=\"El lenacapavir podr\u00eda prevenir hasta 84.000 infecciones de VIH en Am\u00e9rica Latina para 2030, seg\u00fan estimaciones del Instituto Nacional de Salud P\u00fablica (INSP) de M\u00e9xico, pero su acceso sigue bloqueado por licencias privadas, precios inaccesibles y vac\u00edos regulatorios.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/\" \/>\n<meta property=\"og:site_name\" content=\"Americano Newspaper\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AmericanoNewspaper\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-21T00:02:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-21T02:00:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"612\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Harmony Quintana\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Harmony Quintana\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/\"},\"author\":{\"name\":\"Harmony Quintana\",\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/#\\\/schema\\\/person\\\/82c7c1ac5e9a005b627b6c7db5361c90\"},\"headline\":\"Nueva profilaxis que promete frenar el VIH, pero no llega a Am\u00e9rica Latina\",\"datePublished\":\"2025-10-21T00:02:00+00:00\",\"dateModified\":\"2025-10-21T02:00:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/\"},\"wordCount\":624,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg\",\"articleSection\":[\"Am\u00e9rica Latina\",\"Salud\",\"VIH\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/\",\"url\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/\",\"name\":\"Nueva profilaxis que promete frenar el VIH, pero no llega a Am\u00e9rica Latina - Americano Newspaper\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg\",\"datePublished\":\"2025-10-21T00:02:00+00:00\",\"dateModified\":\"2025-10-21T02:00:41+00:00\",\"description\":\"El lenacapavir podr\u00eda prevenir hasta 84.000 infecciones de VIH en Am\u00e9rica Latina para 2030, seg\u00fan estimaciones del Instituto Nacional de Salud P\u00fablica (INSP) de M\u00e9xico, pero su acceso sigue bloqueado por licencias privadas, precios inaccesibles y vac\u00edos regulatorios.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg\",\"contentUrl\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg\",\"width\":900,\"height\":612,\"caption\":\"Un m\u00e9dico del Hospital Fundaci\u00f3n Marco Antonio sostiene una prueva de VIH SIDA en la Ciudad de Guatemala. EFE\\\/ Ulises Rodr\u00edguez\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/salud\\\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nueva profilaxis que promete frenar el VIH, pero no llega a Am\u00e9rica Latina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/\",\"name\":\"Americano Newspaper\",\"description\":\"The Hispanic Newspaper of New Jersey.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/#organization\",\"name\":\"Americano Newspaper\",\"url\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/AmericanoLogoCircle.comCircle2.jpg\",\"contentUrl\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/AmericanoLogoCircle.comCircle2.jpg\",\"width\":600,\"height\":600,\"caption\":\"Americano Newspaper\"},\"image\":{\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AmericanoNewspaper\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/#\\\/schema\\\/person\\\/82c7c1ac5e9a005b627b6c7db5361c90\",\"name\":\"Harmony Quintana\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/wp-content\\\/litespeed\\\/avatar\\\/656e5d40e40a67e90b0fee2acae8a764.jpg?ver=1777427866\",\"url\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/wp-content\\\/litespeed\\\/avatar\\\/656e5d40e40a67e90b0fee2acae8a764.jpg?ver=1777427866\",\"contentUrl\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/wp-content\\\/litespeed\\\/avatar\\\/656e5d40e40a67e90b0fee2acae8a764.jpg?ver=1777427866\",\"caption\":\"Harmony Quintana\"},\"sameAs\":[\"http:\\\/\\\/www.americanonewspaper.com\"],\"url\":\"https:\\\/\\\/www.americanonewspaper.com\\\/es\\\/author\\\/harmony\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Nueva profilaxis que promete frenar el VIH, pero no llega a Am\u00e9rica Latina - Americano Newspaper","description":"El lenacapavir podr\u00eda prevenir hasta 84.000 infecciones de VIH en Am\u00e9rica Latina para 2030, seg\u00fan estimaciones del Instituto Nacional de Salud P\u00fablica (INSP) de M\u00e9xico, pero su acceso sigue bloqueado por licencias privadas, precios inaccesibles y vac\u00edos regulatorios.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/","og_locale":"en_US","og_type":"article","og_title":"Nueva profilaxis que promete frenar el VIH, pero no llega a Am\u00e9rica Latina","og_description":"El lenacapavir podr\u00eda prevenir hasta 84.000 infecciones de VIH en Am\u00e9rica Latina para 2030, seg\u00fan estimaciones del Instituto Nacional de Salud P\u00fablica (INSP) de M\u00e9xico, pero su acceso sigue bloqueado por licencias privadas, precios inaccesibles y vac\u00edos regulatorios.","og_url":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/","og_site_name":"Americano Newspaper","article_publisher":"https:\/\/www.facebook.com\/AmericanoNewspaper\/","article_published_time":"2025-10-21T00:02:00+00:00","article_modified_time":"2025-10-21T02:00:41+00:00","og_image":[{"width":900,"height":612,"url":"https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg","type":"image\/jpeg"}],"author":"Harmony Quintana","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Harmony Quintana","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/#article","isPartOf":{"@id":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/"},"author":{"name":"Harmony Quintana","@id":"https:\/\/www.americanonewspaper.com\/es\/#\/schema\/person\/82c7c1ac5e9a005b627b6c7db5361c90"},"headline":"Nueva profilaxis que promete frenar el VIH, pero no llega a Am\u00e9rica Latina","datePublished":"2025-10-21T00:02:00+00:00","dateModified":"2025-10-21T02:00:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/"},"wordCount":624,"commentCount":0,"publisher":{"@id":"https:\/\/www.americanonewspaper.com\/es\/#organization"},"image":{"@id":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/#primaryimage"},"thumbnailUrl":"https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg","articleSection":["Am\u00e9rica Latina","Salud","VIH"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/","url":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/","name":"Nueva profilaxis que promete frenar el VIH, pero no llega a Am\u00e9rica Latina - Americano Newspaper","isPartOf":{"@id":"https:\/\/www.americanonewspaper.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/#primaryimage"},"image":{"@id":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/#primaryimage"},"thumbnailUrl":"https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg","datePublished":"2025-10-21T00:02:00+00:00","dateModified":"2025-10-21T02:00:41+00:00","description":"El lenacapavir podr\u00eda prevenir hasta 84.000 infecciones de VIH en Am\u00e9rica Latina para 2030, seg\u00fan estimaciones del Instituto Nacional de Salud P\u00fablica (INSP) de M\u00e9xico, pero su acceso sigue bloqueado por licencias privadas, precios inaccesibles y vac\u00edos regulatorios.","breadcrumb":{"@id":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/#primaryimage","url":"https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg","contentUrl":"https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg","width":900,"height":612,"caption":"Un m\u00e9dico del Hospital Fundaci\u00f3n Marco Antonio sostiene una prueva de VIH SIDA en la Ciudad de Guatemala. EFE\/ Ulises Rodr\u00edguez"},{"@type":"BreadcrumbList","@id":"https:\/\/www.americanonewspaper.com\/es\/salud\/nueva-profilaxis-que-promete-frenar-el-vih-pero-no-llega-a-america-latina\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.americanonewspaper.com\/es\/"},{"@type":"ListItem","position":2,"name":"Nueva profilaxis que promete frenar el VIH, pero no llega a Am\u00e9rica Latina"}]},{"@type":"WebSite","@id":"https:\/\/www.americanonewspaper.com\/es\/#website","url":"https:\/\/www.americanonewspaper.com\/es\/","name":"Americano Newspaper","description":"The Hispanic Newspaper of New Jersey.","publisher":{"@id":"https:\/\/www.americanonewspaper.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.americanonewspaper.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.americanonewspaper.com\/es\/#organization","name":"Americano Newspaper","url":"https:\/\/www.americanonewspaper.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.americanonewspaper.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2024\/05\/AmericanoLogoCircle.comCircle2.jpg","contentUrl":"https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2024\/05\/AmericanoLogoCircle.comCircle2.jpg","width":600,"height":600,"caption":"Americano Newspaper"},"image":{"@id":"https:\/\/www.americanonewspaper.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AmericanoNewspaper\/"]},{"@type":"Person","@id":"https:\/\/www.americanonewspaper.com\/es\/#\/schema\/person\/82c7c1ac5e9a005b627b6c7db5361c90","name":"Harmony Quintana","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.americanonewspaper.com\/es\/wp-content\/litespeed\/avatar\/656e5d40e40a67e90b0fee2acae8a764.jpg?ver=1777427866","url":"https:\/\/www.americanonewspaper.com\/es\/wp-content\/litespeed\/avatar\/656e5d40e40a67e90b0fee2acae8a764.jpg?ver=1777427866","contentUrl":"https:\/\/www.americanonewspaper.com\/es\/wp-content\/litespeed\/avatar\/656e5d40e40a67e90b0fee2acae8a764.jpg?ver=1777427866","caption":"Harmony Quintana"},"sameAs":["http:\/\/www.americanonewspaper.com"],"url":"https:\/\/www.americanonewspaper.com\/es\/author\/harmony\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg","featured_image_urls":{"full":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg",900,612,false],"thumbnail":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw-250x250.jpg",250,250,true],"medium":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw-300x204.jpg",300,204,true],"medium_large":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw-768x522.jpg",696,473,true],"large":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw-735x500.jpg",696,473,true],"1536x1536":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg",900,612,false],"2048x2048":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg",900,612,false],"td_150x0":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw-150x102.jpg",150,102,true],"td_218x150":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw-218x150.jpg",218,150,true],"td_300x0":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw-300x204.jpg",300,204,true],"td_324x400":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw-324x400.jpg",324,400,true],"td_485x360":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw-485x360.jpg",485,360,true],"td_696x0":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw-696x473.jpg",696,473,true],"td_1068x0":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg",900,612,false],"td_1920x0":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw.jpg",900,612,false],"bdpp-medium":["https:\/\/www.americanonewspaper.com\/es\/wp-content\/uploads\/2025\/10\/2a95c8f30f8981f26f9eedd2312c9a605721bca8miniw-640x480.jpg",640,480,true]},"author_info":{"display_name":"Harmony Quintana","author_link":"https:\/\/www.americanonewspaper.com\/es\/author\/harmony\/"},"category_info":"<a href=\"https:\/\/www.americanonewspaper.com\/es\/category\/america-latina\/\" rel=\"category tag\">Am\u00e9rica Latina<\/a> <a href=\"https:\/\/www.americanonewspaper.com\/es\/category\/salud\/\" rel=\"category tag\">Salud<\/a> <a href=\"https:\/\/www.americanonewspaper.com\/es\/category\/vih\/\" rel=\"category tag\">VIH<\/a>","tag_info":"VIH","comment_count":"0","jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/www.americanonewspaper.com\/es\/wp-json\/wp\/v2\/posts\/29504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.americanonewspaper.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.americanonewspaper.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.americanonewspaper.com\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.americanonewspaper.com\/es\/wp-json\/wp\/v2\/comments?post=29504"}],"version-history":[{"count":1,"href":"https:\/\/www.americanonewspaper.com\/es\/wp-json\/wp\/v2\/posts\/29504\/revisions"}],"predecessor-version":[{"id":29506,"href":"https:\/\/www.americanonewspaper.com\/es\/wp-json\/wp\/v2\/posts\/29504\/revisions\/29506"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.americanonewspaper.com\/es\/wp-json\/wp\/v2\/media\/29505"}],"wp:attachment":[{"href":"https:\/\/www.americanonewspaper.com\/es\/wp-json\/wp\/v2\/media?parent=29504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.americanonewspaper.com\/es\/wp-json\/wp\/v2\/categories?post=29504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.americanonewspaper.com\/es\/wp-json\/wp\/v2\/tags?post=29504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}